Related Experiment Video

Updated: Aug 8, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness

Yaqin Zhang1, Baolin Zhang

  • 1Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.

Cancer Research
|June 3, 2006
PubMed

Insights

D4-GDI, a Rho GDP dissociation inhibitor, is expressed in breast cancer cells and drives their invasive properties. Inhibiting D4-GDI blocks cell motility, invasion, and beta1-integrin expression, reverting cancer cells to a normal phenotype.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • D4-GDI (Discs large-associated protein 1) is a Rho GDP dissociation inhibitor.
  • It is widely expressed in hematopoietic cells.
  • Its role in breast cancer remains uncharacterized.

Purpose of the Study:

  • To investigate the expression and function of D4-GDI in breast cancer cells.
  • To determine if D4-GDI influences breast cancer cell motility, invasion, and phenotype.

Main Methods:

  • D4-GDI expression was assessed in breast cancer cell lines and benign mammary epithelial cells.
  • RNA interference was used to knock down D4-GDI in MDA-MB-231 and BT549 cells.
  • Cell motility, invasion, beta1-integrin expression, and cell-matrix adhesion were analyzed.
  • Reintroduction of D4-GDI was performed to confirm its role.

Main Results:

  • D4-GDI is expressed in breast cancer cell lines but not in benign mammary epithelial cells.
  • Knockdown of D4-GDI significantly inhibited cell motility and invasion in MDA-MB-231 cells.
  • D4-GDI silencing led to reversion to a normal epithelial phenotype, reduced beta1-integrin expression, and decreased cell-matrix adhesion.
  • Reintroduction of D4-GDI restored invasive properties and beta1-integrin expression.
  • Similar effects were observed in BT549 cells.

Conclusions:

  • D4-GDI is upregulated in breast cancer cells.
  • D4-GDI plays a crucial role in modulating breast cancer cell invasive activities.
  • D4-GDI is a potential therapeutic target for inhibiting breast cancer metastasis.

More Related Videos

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model

Published on: June 11, 2014

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...